Management of alveolar rhabdomyosarcoma of the orbit.
Seregard
Stefan
S
Opthalmic Pathology and Oncology Service, St Erik's Eye Hospital, Stockholm, Sweden. stefan.sergard@sankterik.se
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003609:Dactinomycin / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007223:Infant; D008279:Magnetic Resonance Imaging; D013508:Ophthalmologic Surgical Procedures; D009918:Orbital Neoplasms / Q000473:pathology / Q000628:therapy*; D018232:Rhabdomyosarcoma, Alveolar / Q000473:pathology / Q000628:therapy*; D014750:Vincristine / Q000008:administration & dosage
D003609:Dactinomycin; D014750:Vincristine; D004317:Doxorubicin; D007069:Ifosfamide